Kuzbicki et al. (48) found that the average level of COX-2 expression in melanoma samples was significantly higher than that in benign nevi, and COX-2 expression in tumor tissues with lymph node metastasis was significantly higher than that in non-metastatic melanoma (48). Here, PTGS2 is linked to melanoma.